PLATELETS IN HYPERTHYROIDISM - STUDIES ON PLATELET COUNTS, MEAN PLATELET VOLUME, INDIUM-111-LABELED PLATELET KINETICS, AND PLATELET-ASSOCIATED IMMUNOGLOBULIN-G AND IMMUNOGLOBULIN-M

被引:59
作者
PANZER, S [1 ]
HAUBENSTOCK, A [1 ]
MINAR, E [1 ]
机构
[1] UNIV VIENNA, MED 1 CLIN, A-1010 VIENNA, AUSTRIA
关键词
D O I
10.1210/jcem-70-2-491
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We compared in 15 patients with hyperthyroidism (11 with Graves' disease, 3 with toxic adenoma, and 1 with multinodular goiter) platelet counts (PC) and mean platelet volume (MPV) before and 3 weeks after initiation of antithyroid drug therapy when the patients were euthyroid. In addition, platelet kinetic studies of autologous 111-indium-labeled platelets and platelet-associated immunoglobulins G and M (PAIgG and PAIgM, respectively) were investigated. The control group for the platelet kinetic studies consisted of 2 patients with diffuse nontoxic goiter and 86 patients who were studied for evaluation of their arteriosclerotic vascular disease. After 3 weeks of antithyroid drug therapy there was a significant increase in PC and a decrease in MPV compared with the pretreatment values (pretreatment PC median, 215 × 109/L; range, 96–350 × 109/L; PC median 3 weeks later, 248 × 109/L; range, 157 – 384 × 109/L; P < 0.005; pretreatment MPV median, 10.6 fL; range, 9.1–13.2 fL; MPV 3 weeks later, 9.9 fL; range, 8.4–11.0 fL; P < 0.005). Ill-Indium platelet recovery was normal in all subjects. Plateletlifespan was significantly shortened in the patients with hyperthyroidism compared with the control group (median, 163.8 h; range, 128.5–206 h; vs. 180.0 h; range, 138.3–231.5 h; P< 0.05). Platelet turnover averaged 45.6 (range, 25.6–71.9) × 109/·day; values above the limit of normal were found in 7 of 15 patients with hyperthyroidism. Three patients with Graves' disease had elevated levels of PAIgG; 1 of these patients had elevated levels of PAIgM and was the only patient with thrombocytopenia (PC, 96 × 109/L). Various combinations of statistical correlations between the degree of hyperthyroidism, pretreatment PC and MPV, platelet kinetic studies, levels of PAIg, and serum levels of antithyroid antibodies revealed no significant differences. These findings suggestthat the platelet changes observed in hyperthyroidism, such as lower PC and increased MPV, together with the shortened platelet lifespan reflect metabolically rather than immunologically mediated phenomena, although these may be involved in cases with marked thrombocytopenia. © 1990 by The Endocrine Society.
引用
收藏
页码:491 / 496
页数:6
相关论文
共 34 条
[1]   VARIABLE PRESENTATION OF THROMBOCYTOPENIA IN GRAVES-DISEASE [J].
ADROUNY, A ;
SANDLER, RM ;
CARMEL, R .
ARCHIVES OF INTERNAL MEDICINE, 1982, 142 (08) :1460-1464
[3]   THE BONE MARROW IN HYPERTHYROIDISM AND HYPOTHYROIDISM [J].
AXELROD, AR ;
BERMAN, L .
BLOOD, 1951, 6 (05) :436-453
[4]   Splenic enlargement in hyperthyroidism [J].
Baldridge, CW ;
Peterson, FR .
JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1927, 88 :1701-1702
[5]  
BESSMAN JD, 1981, AM J CLIN PATHOL, V76, P289
[6]   ANTITHYROID DRUGS [J].
COOPER, DS .
NEW ENGLAND JOURNAL OF MEDICINE, 1984, 311 (21) :1353-1362
[7]   MEAN PLATELET VOLUME IS INCREASED IN HYPERTHYROIDISM [J].
FORD, HC ;
TOOMATH, RJ ;
CARTER, JM ;
DELAHUNT, JW ;
FAGERSTROM, JN .
AMERICAN JOURNAL OF HEMATOLOGY, 1988, 27 (03) :190-193
[8]   PLATELET SURVIVAL AND THE DEVELOPMENT OF CORONARY-ARTERY DISEASE IN THE YOUNG-ADULT - EFFECTS OF CIGARETTE-SMOKING, STRONG FAMILY HISTORY AND MEDICAL THERAPY [J].
FUSTER, V ;
CHESEBRO, JH ;
FRYE, RL ;
ELVEBACK, LR .
CIRCULATION, 1981, 63 (03) :546-551
[9]  
GIRSH LS, 1957, AM J CLIN PATHOL, V27, P328
[10]   THROMBOKINETICS IN MAN [J].
HARKER, LA ;
FINCH, CA .
JOURNAL OF CLINICAL INVESTIGATION, 1969, 48 (06) :963-&